| (Values in U.S. Thousands) | Dec, 2017 | Sep, 2017 | Jun, 2017 | Mar, 2017 | Dec, 2016 |
| Sales | -9,999,000 | 23,330 | 22,140 | 19,110 | 21,670 |
| Sales Growth | -42,958.98% | +5.37% | +15.86% | -11.81% | +21.20% |
| Net Income | -9,999,000 | -3,240 | -8,040 | -8,330 | -7,310 |
| Net Income Growth | -308,511.11% | +59.70% | +3.48% | -13.95% | +23.21% |
Entellus Medical (ENTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Entellus Medical, Inc. is a medical technology company. It is engaged in the designing, development and commercialization of products for the treatment of chronic sinusitis. The company operates primarily in the United States and Canada. Entellus Medical, Inc. is headquartered in Plymouth, Minnesota.
Fiscal Year End Date: 12/31